Development and validation of bioanalytical uv-spectrophotometric method for determination of candesartan and development and validation of uv-spectrophotometric method for determination of candesartan in bulk drug and formulation

The accurate, precise, sensitive and economical spectrophotometric bioanalytical method was developed and validated for estimation of candesartan in plasma. The UV method was also employed for estimation of candesartan in bulk drug and in dosage form. The absorption maximum found for candesartan was 245nm. The correlation coefficient was found to be 0.999. The mean recovery for candesartan was found to be 99.92%. The developed method was validated according to ICH guidelines and values of accuracy, precision and other statistical analysis were found to be in good accordance with the prescribed values. Thus the proposed method was successfully applied for estimation of candesartan in plasma and for routine industrial work.